Product Information
GABAPENTIN 800 MG TABLET is a generic product labeled by BluePoint Laboratories, priced at $0.0963 per EA under NDC 68001041203. Its NADAC has been published 334 times since Feb 5, 2020.
Strength
800 mg/1
Manufacturer
BluePoint LaboratoriesNDC
68001041203
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
GABAPENTINApproval Type
Generic (ANDA)
FDA Application
ANDA077662On Market Since
9/30/2019
Pharmacological Classes
Price Statistics
The NADAC for GABAPENTIN 800 MG TABLET has been published 334 times since Feb 5, 2020, and over the history we have for it it has declined 26.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0963 per EA |
|---|---|
| All-time high | $0.1347 (Apr 14, 2021) |
| All-time low | $0.0799 (Nov 20, 2024) |
| 52-week high | $0.1035 |
| 52-week low | $0.0963 |
| Median price | $0.1234 |
| Average price | $0.1173 |
| Largest weekly change | -27.0% (Nov 20, 2024) |
| Weeks tracked | 334 |
| Tracking since | Feb 5, 2020 |
Generic Alternatives
The matcher finds 21 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of GABAPENTIN 800 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for GABAPENTIN 800 MG TABLET, manufactured by BluePoint Laboratories, is $0.0963 per EA (NDC 68001041203), effective Jun 24, 2026.
How has the price of GABAPENTIN 800 MG TABLET changed over time?
Over the history we have for it, the NADAC for GABAPENTIN 800 MG TABLET has declined 26.6%. It has been tracked across 334 weekly CMS publications since Feb 5, 2020.
What are the highest and lowest recorded NADAC prices for GABAPENTIN 800 MG TABLET?
Since Feb 5, 2020, the NADAC for GABAPENTIN 800 MG TABLET has ranged from a low of $0.0799 (Nov 20, 2024) to a high of $0.1347 (Apr 14, 2021), with a median of $0.1234 per EA.
Are there cheaper alternatives to GABAPENTIN 800 MG TABLET?
21 NADAC-published products share the same active ingredient, strength, and dosage form as GABAPENTIN 800 MG TABLET, but none are currently priced below it.
Who manufactures GABAPENTIN 800 MG TABLET?
GABAPENTIN 800 MG TABLET (NDC 68001041203) is labeled by BluePoint Laboratories, and CMS classifies it as a generic product.
Related Drugs
Same classification